Larrea divaricata Cav.: evidencia específica mostrando sus efectos beneficiosos y su amplia aplicación potencial by DAVICINO, Roberto et al.
  
© 2011 The Authors 
© 2011 Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 10 (2): 92 - 103 
BLACPMA ISSN 0717 7917 
 
Revisión | Review 
92 
 
 
Larrea divaricata Cav.: Scientific evidence showing its beneficial effects 
and its wide potential application. 
 
 [Larrea divaricata Cav.: evidencia específica mostrando sus efectos beneficiosos y su amplia aplicación potencial] 
 
 
Roberto DAVICINO, Renzo MARTINO & Claudia ANESINI * 
 
 
Instituto de Química y Metabolismo del Fármaco- Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y 
Técnicas (IQUIMEFA-UBA-CONICET), Junín 956, Universidad de Buenos Aires, Buenos Aires, Argentina. 
Contactos | Contacts: Claudia ANESINI E-mail address: canesini@yahoo.com.ar 
 
Abstract  
Larrea divaricata Cav. (jarilla) (Zygophyllaceae) is used in Argentinean folk medicine. It contains nordihydroguaiaretic acid (NDGA), a lignan with 
nefrotoxic and hepatotoxic effects. The presence of NDGA converts controversial the use of L. divaricata. The amount of NDGA is higher in alcoholic 
extracts than in aqueous extracts (AE). The last 20 years had a great advance on the use of AE to treat different conditions in a safe manner. In this review, we 
present the scientific results tending to confirm the potential beneficial effects of the AE on human health. The anti-proliferative effects of AE of L. divaricata 
have been assayed on a tumor lymphoid line (BW 5147) and the pathways involved in such effects were described. The anti-microbial activity was 
determined by tests for bacteria and fungus. The anti-inflammatory activity was assayed by using carrageen and TPA induced-inflammation tests. The 
Immunomodulatory effects were investigated ―in vivo‖ and ―in vitro‖ on mice. Sub-fractions of aqueous extracts were obtained and analyzed. The 
immunogenicity of proteins from crude AE was characterized and antioxidant and nutritional activity were studied. The effect of an AE on hair loss was 
assayed. In summary, AE from L. divaricata has pharmacological activities including anti-microbial, anti-inflammatory, anti-cancer effects.  
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Resumen 
Larrea divaricata Cav. (Jarilla) (Zygophyllaceae) es utilizada en medicina popular Argentina. Contiene ácido nordihidroguaiarético (NDGA), un lignano con 
efectos nefrotóxicos y hepatotóxicos. La presencia de NDGA hace controvertido el uso de L. divaricata. La cantidad de NDGA es mayor en extractos 
alcohólicos que en extractos acuosos (EA). Los últimos 20 años han tenido un gran avance en el uso de EA para el tratamiento de diferentes condiciones en 
forma segura. En esta revisión se presentan  resultados científicos que confirman los efectos potencialmente beneficiosos de los EA sobre la salud humana. 
Los efectos anti-proliferativos se han ensayado en una línea de tumor linfoide, así como los mecanismos involucrados. La actividad anti-microbiana se 
determinó usando pruebas para bacterias y hongos. La actividad anti-inflamatoria fue evaluada mediante el uso de inflamación inducida por carragenina y 
TPA. Los efectos inmunomoduladores fueron investigados "in vivo" e "in vitro" en ratones. Sub-fracciones de los EA fueron obtenidos y analizados. La 
inmunogenicidad de las proteínas del EA crudo se caracterizaron y se estudiaron las actividades antioxidantes nutricionales. Además, se ensayó el efecto del 
EA en la caída del cabello. En resumen, los EA de L. divaricata presentan actividades farmacológicas como por ejemplo, anti-microbiana, anti-inflamatoria y 
efectos anti-cancerígenos. 
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INTRODUCTION 
Plant extracts have been used in folk medicine since 
remote times until now. Already 2000 years B.C, the 
Sumerian civilization used poppy and other 700 
medicinal preparations (Cambría, 1993). Hypocrates, 
500 years b.C mentioned 300-400 medicinal plants. In 
the first century a.C, Discorides organized ―The 
Materia Medica‖, a catalog of medicinal plants. Even 
in the Bible there is a description of about 30 
medicinal plants (Kanba et al., 1998; Lewis, 2001). In 
this sence; pharmaceuticals have been with us less 
than 150 years. If our ancestors left Africa via the 
Holy Land 2000 years ago (for faith-based literalists), 
maybe a million years ago (for the less literal), then 
our genes, tracing back to our African/Holy Land 
ancestors, have had at least ten times more temporal 
experience with biblical herbs (e.g., cinnamon, 
coriander, cumin, dill, garlic, grape, mint, milk thistle, 
myrrh, olive, onion, pomegranate, saffron, turmeric, 
and the like). Besides, our bodies may even require 
many of them. Pharmaceuticals and synthetic food 
additives are relatively new to our genes. (Duke et al., 
2008)   
On the other hand, around 80% of the world´s 
population, mainly in non-developed countries, has in 
natural products as the first option for medication in 
Primary Health Care (Núñez-Sellés et al., 2007).  
Larrea divaricata Cav. (Zygophyllaceae) is 
widely distributed in north-west, center, and south-east 
of Argentine (Discole et al., 1940). It is an evergreen 
shrub of 3 to 6 feet (0.9 to 1.8 m) tall. The small, dark 
green, resinous leaves are borne mostly at the tips of 
twigs and the rest of the branches are bare. Small 
yellow flowers appear throughout the year following 
rains. The fruit is a small woolly ball (Fig. 1).   
In folk medicine, L. divaricata have the 
following claims and uses: healing sores and wounds, 
rheumatism, inflammation of respiratory and intestinal 
tract, gastric disturbance, venereal diseases, tonic, 
corrective, antiseptic, stimulating expectorant, emetic, 
(Waller and Gisvold, 1945), arthritis, cancer (Lambert 
et al., 2002), tuberculosis (Copp and Pearce, 2007; 
Rodriguez-Fragoso et al., 2008; Tyler and Foster, 
1999) common cold (Tyler and Foster, 1999) and 
rubefascient (Del Vitto et al., 1997). Larrea divaricata 
contains NDGA (Mabry et al., 1977), a lignan with 
reported nefrotoxic and hepatotoxic effects (Arteaga et 
al., 2005). Therefore, the presence of NDGA makes 
controversial the use of L. divaricata to treat diseases 
by which their uses and applications were limited.  
 
 
 
 
Figure 1.  Larrea divaricata Cav. is an evergreen shrub of 
0.9 to 1.8 m tall. The small, dark green, resinous leaves are 
borne mostly at the tips of twigs and the rest of the branches 
are bare. The flowers are yellow and the fruit is a small ball. 
 
NDGA has an inhibitory effect on 
inflammatory cytokines during the acute phase and 
can act as a scavenger of free radicals generated 
during inflammatory processes (Schreck et al., 1992). 
NDGA is soluble in ethanol, slightly soluble in hot 
water, and insoluble in cold water (Coy and Gisvold, 
1944). These properties reduce significantly the 
amount of NDGA in aqueous extracts (AE) compared 
with alcoholic extracts (Obermeyer et al., 1995; 
Davicino et al., 2006; Davicino et al., unpublished 
results).  
The chemical composition of Larrea 
divaricata has been studied previously. It was found to 
contain principally phenolic compounds such as 
NDGA, essential oils (limonene, camphene, borneol 
and alcanfor) (Mabry et al., 1977), dihydroguaiaretic 
acid, norisoguaiacin, 3 -demethoxyisoguaiacin and 20 
flavonoids (Mabry et al., 1977). The presence of 
saponins and leucoantocianidines was also reported 
(Bandoni et al., 1971). Among the flavonoids, O-
glycosides of quercitin, myricetin and a C-glycoside of 
apigenin were found (Timmerman et al., 1979). 
Davicino et al. (unpublished results) showed the 
presence of a polar derivate from NDGA in an AE 
obtained from this plant. 
During long time Larrea divaricata Cav. was 
confused with Larrea tridentata. Initially they were 
considered to be sub species but now they are 
separated into two different species. In fact, they have 
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different active compounds (Horm and Gisvold, 1945; 
Sakakibara et al., 1976) and distinct genetic 
composition (Palacio and Hunziker, 1972; Yang, 
1970). Because of this, the majority of studies about 
toxic effect of Larrea spp. are referred to L. tridentata. 
The toxicity of L. tridentata was observed after the 
consumption of leaf preparation (Katz and Saibil, 
1990; Gordon et al., 1995; Batchelor et al., 1995). In 
these preparations 5-10 % of NDGA was found; as 
NDGA has been considered to be principally 
nephrotoxic and hepatotoxic, the toxicity of the plant 
was attributed mainly to this compound (Stickel et al., 
2000). The toxicity of L. divaricata is discussed 
below, in relation to its NDGA content. 
The question then is: it is possible to use the 
AE from L. divaricata to treat the diseases related with 
it use in folk medicine? 
In this review we present scientific reports 
tending to confirm the potential benefit of the AE 
obtained from L. divaricata, on human health and also 
we propose a novel mechanism by which AE could be 
exert its anti-tumor effect. 
 
PHARMACOLOGY  
Anti-tumor effects 
Chemoprevention by medicinal plants has received 
growing attention in recent years as a promising 
approach in controlling the incidence of cancer 
(Mettlin, 1997). It has been demonstrated that an AE 
of L. divaricata has a dual effect upon the tumor 
lymphoid cells BW 5147: an anti-proliferative activity 
at high concentrations and a pro-proliferative activity 
at low concentration. This cellular line corresponds to 
a murine immature T-lymphoma with H-2k haplotype 
and α  T cell receptor (α TCR). These cells express 
CD3, CD4, CD28 and -adrenoreceptors (Criado and 
Rojo, 2000; Gorelik et al., 2002; Wegener et al., 1992; 
Clavreul et al., 2000).  
In previous studies, it is demonstrated that the 
anti-proliferative action of the AE of L. divaricata on 
BW5147 cells is related to an increase in cAMP levels, 
this effect appeared not to be mediated by the 
activation of receptors coupled to cAMP (beta 
adrenergic receptors and histaminergic receptors) 
(Anesini el al., 1996). It is important to note that these 
cells show a poor expression of -adrenoreceptors 
(Cremaschi et al., 1991), moreover these receptors are 
uncoupled to the adenylate cyclase system. This last is 
related to the phosphorylation performed by protein 
kinase C (PKC) (Cremaschi et al., 2000). The increase 
in cAMP exerted by L. divaricata extract could be 
related to the inactivation of the PKC previously 
observed. The BW 5147 cells expressed mainly PKC  
, this is a calcium independent isoform (Gorelik et al., 
2002; Hirai and Chida, 2003; Moscat and Diaz-Meco, 
2005) meanwhile, these cells have barely detectable 
levels of the  isoform from PKC, with similar levels 
of α and  isoforms, and no detectable levels of the  
and  isoenzymes.  Generally, cellular proliferation is 
mainly calcium independent so, PKC activity involves 
calcium-independent isoforms. Based on these facts, it 
is possible that the increase in PKC  isoform 
observed during mitogenic stimulation of T cells 
would allow an efficient but limited activation, leading 
to differentiation to immune effectors cells, while low 
levels of this isoenzyme, along with high levels of the 
 isoform, would be responsible for the 
hyperproliferative pattern of BW5147 cell line 
(Gorelik et al., 2002). L. divaricata extract could 
inhibit directly the  isoform of PKC. By the other 
hand, eicosanoids such as leukotrienes and 
prostaglandins have been related to the modulation of 
cell proliferation through the action exert not only on 
cAMP level, but also on PKC activation (Nishizuka, 
1988; Parker et al., 1989). For example, leukotriene 
B4 (LTB4) exerts a pro-proliferative effect on 
BW5147 cell line, by deceasing cAMP levels and by 
the induction of PCK. In a recent publication, 
Davicino et al. (2011) were able to show that the AE 
has a dual effect on cell proliferation: first increases 
cAMP levels and inhibits PKC, producing a depleting 
effect on proliferation, but on the other hand induces 
LTB4 production, which antagonizes the anti-
proliferative effects. However, the end result is a clear 
anti-proliferative effect. They conclude that the effect 
of the extract on leukotrienes decreases the anti-
proliferative action, and the extract exerts an anti-
proliferative effect due to cAMP production and PKC 
inhibition.  
It is known that the treatment of cells with 
H2O2 may causes activation of NF- B, phenomenon 
related to apoptosis and to a decrease in cell 
proliferation by the induction of NO level. In 
lymphocytes, H2O2 is produced from mitochondria 
during respiration and can diffuse to cytosol (Rezaei et 
al., 2008). In the first step, superoxide free radical is 
simultaneously reduced and oxidized (dismutated) to 
form hydrogen peroxide and oxygen. This is 
accomplished by superoxide dismutase (SOD). In the 
second step, hydrogen peroxide is converted into water 
and oxygen. There is increasing evidence to suggest 
that H2O2 generated at low levels during normal cell 
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signaling may act as a second messenger (Lee and 
Esselman, 2001). Recently, Davicino et al. (2009a) 
advanced on the studies and analyzed the participation 
of H2O2 in the anti-proliferative effect of L. divaricata 
on BW 5147 cells.  Different assays were performed 
showing that the inhibition of cell proliferation was 
related to activation of ERK1/2 pathway and the 
subsequent translocation of NF-κB to the nucleus 
leading to the induction of iNOS (inducible nitric 
oxide sintase) and the consequent increase of NO 
level, which in turn activates P-38 pathway leading to 
apoptosis. Moreover, it was observed that BW5147 
lymphocytes need to have low levels of H2O2 to allow 
the proliferation, this requirement can be 
accomplished by maintaining a low Mn
2+
SOD and 
high peroxidase (Px) activities. L. divaricata increased 
the activity of SOD which leads to increase H2O2 
(Davicino et al., 2010).  
On the other hand, it is known that H2O2 is 
capable of affecting the function of proteins by 
oxidizing thiol groups in Cys amino acid residues to 
sulfenic acid (Lee and Esselman, 2001). In Jurkat T 
lymphocytes, H2O2 enhanced the phosphorylation 
level of ERK1/2 caused by T cell receptor (TCR) 
stimulation. Sub-millimolar concentrations of H2O2 
induced phosphorylation of ERK1/2 and MEK1/2 
without antigenic stimulation, leading to cell 
proliferation. Interestingly, when intracellular cAMP 
levels were increased, it inhibits upstream signaling 
pathways activated by H2O2, resulting in decrease of 
H2O2-induced MEK1/2 phosphorylation. H2O2 also 
inhibits ERK-dephosphorylating phosphatases (PTPs) 
that may be dissociated from ERK1/2 by PKA 
phosphorylation, leading to overall enhancement of 
ERK1/2 phosphorylation by cAMP (Lee and 
Esselman, 2001). Besides, CD28 co-stimulation 
produces H2O2 by 5-lipoxygenase (5-Lox), resulting in 
IL-2 gene expression through NF-kB activation. 
Treatment of cells with low concentrations of H2O2 
was previously shown to enhance IL-2 gene 
expression after TCR activation, as well as 
mitogenically induced T cell proliferation (Hehner et 
al., 2000; Los et al., 1995). When BW5147 cells are 
treated with high concentrations of AE of L. divaricata 
(100-1000 g/ml) probably it produces high amounts 
of mitochondrial H2O2 by Mn
2+
SOD stimulation 
(Davicino et al., 2010). The H2O2 produced may act on 
the PTPs that inhibit ERK1/2 and thus lead to 
production of NO that finally triggers apoptosis. The 
extract also increases the intracellular cAMP which 
could act promoting the anti-proliferative action of 
H2O2. L. divaricata could directly activate adenylate 
cyclase to produce more amount of cAMP. In accord 
to these findings, we propose in Figure 2 an overall 
review of the potential mechanism by which AE 
obtained from L. divaricata could exert the anti-
proliferative effects on BW5147 cells. 
 
Although it has been demonstrated the anti-
proliferative activity of L. divaricata, Anesini et al.,  
(1999), by using inhibitors, demonstrated that at low 
concentration (0.5 g/ml) showed pro-proliferative 
effect, which was due to the activation of lipoxygenase 
metabolism. They also reported the effects of an AE 
from L. divaricata in comparison with the effect of 
NDGA on proliferation of BW5147 cells (Anesini et 
al., 2001). Considering the amount of NDGA detected 
in the extract, the anti-proliferative activity of L. 
divaricata should not be attributed to NDGA. 
According to the preceding paragraph it can be 
suggested that the increase in BW 5147 cells 
proliferation exerted by low concentration of L. 
divaricata extract (0.5 µg/ml) could be related to a 
compound that stimulates the production of H2O2 
which in turn induces proliferation through the 
pathway of arachidonic acid. This observation is 
supported on previously results, that shows that low 
concentrations of H2O2 (10
-8 
- 10
-13
 M) leads to 
BW5147 cells to proliferate and high concentrations of 
H2O2 (10
-3 
- 10
-5
 M) induces cells to apoptosis 
(Davicino et al., 2009a). The authors also showed that 
BW5147 cells do not display SOD activity and 
possessed elevated levels of superoxide (Davicino et 
al., 2009a). This observation suggests that these cells 
are less sensitive to superoxide than to H2O2.   
The anti-tumor activity ―in vivo‖ of an AE of 
L. divaricata was studied on spontaneous and 
chemically induced carcinomas. The extract exerted 
anti-tumor action at 25 mg/kg when was administered 
to a pregnant rat with a spontaneous mammary 
carcinoma and also the anti-tumor activity was shown 
when mammary carcinoma was induced with N-
nitroso-N-methylurea (NMU) in female rats (Anesini 
et al., 1997). In this study from a total of 75 tumors, a 
regression of 10 tumors (13%), a stabilization of 60 
tumors (80%) and an increment of 5 tumors (6%) were 
observed. None of the 80 control tumors decreased 
(0%) and only 12 remained static (15%). In this case 
the extract increases the survival time of the animals in 
comparison with control ones (Anesini et al., 1997). 
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Figure 2. Proposed mechanism for pharmacological action of aqueous extract obtained from Larrea divaricata Cav. on 
BW5147 tumor cells. 
 
Finally, Bongiovanni et al. (2008) demons-
trated that methanolic and methane dichloride extracts 
of aerial parts of Larrea divaricata exhibited a 
pronounced cytotoxic effect by arresting cell viability 
at a level of 35% against the MCF-7 cell line (a human 
breast adenocarcinoma), while only a weak cytotoxic 
effect was observed for the aqueous extract. Apoptosis 
measured by flow cytometry revealed that methanolic 
and methane dichloride extracts resulted in a rapid cell 
plasma membrane perturbation and triggered cellular 
death. 
 
Anti-microbial effects. 
The studies performed with plant extracts in the field 
of infections reveled that plants are potential sources 
of anti-microbial agents. It was shown that, an AE 
obtained from L. divaricata displays remarkable 
activity against Staphylococcus aureus obtaining an 
equivalence of 15.2  1.0 µg/ml with Cephazolin used 
as reference antibiotic (Anesini & Perez, 1993). Stege 
et al. (2006) showed that cold extract, infusion and 
decoction of L. divaricata has inhibitory activity at 
40–100 µg/ml against clarithromycin and 
metronidazole susceptible and resistant Helicobacter 
pylori strains. Besides, these results support the 
popular use of L. divaricata in gastric disturbances 
such as gastric ulcers and gastric cancer associated 
with H. pylori.  On the other hand, it has been 
demonstrated the antifungal activity of an AE of L. 
divaricata at 100 mg/ml against Saccharomyces 
cereviceae (Davicino et al., 2007a) which is a 
common colonizer of mucous membranes causing 
both superficial and invasive deep infections (Aucott 
et al., 1990; Jones et al., 2002). 
The ethanolic extract also inhibits the in vitro 
growth of the following fungi and yeasts: Lenzites 
elegans, Schizophyllum commune, Pycnoporus 
sanguineus, Ganoderma applanatum, Fusarium 
oxysporum, Penicillium notatum, Aspergillus niger, 
and Trichorerma spp. A fraction obtained from this 
ethanolic extract (Fr. B) has several phenolic 
compounds that are responsible of the cytotoxicity 
observed on P. sanguineus, L. elegans and G. 
applanatum (Quiroga et al., 2004). Although ethanolic 
extracts have better fungicidal effects than aqueous 
extracts, little is known about the potential toxic 
effects on humans, due to its higher content of NDGA. 
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Anti-inflammatory activity 
Although in folk medicine, L. divaricata is widely 
used as anti-inflammatory (Del Vitto et al., 1997), 
there are few works documenting this activity. 
Pedernera et al. (2006) determined the anti-
inflammatory effect of L. divaricata but using only a 
methanol extract. Others authors observed that L. 
divaricata at 33.4 mg/kg decreases carrageen and TPA 
induced-inflammation in mice. In these animals a 
decrease of TNF-alpha, IL-6 and eosinophil and an 
increase of IL-10 were observed (Davicino et al., 
unpublished results). These results support that the 
anti-inflammatory effect exerts by L. divaricata could 
be due to a decrease of pro-inflammatory cytokines 
and an increase of anti-inflammatory cytokines. 
 
Immunomodulatory effects 
The impact of the immune system in human ailments 
is enormous. In this sense, autoimmune diseases, type 
I diabetes mellitus, systemic lupus erythematosus, 
multiple sclerosis, solid tumors, hematologic 
malignancies, infectious diseases, asthma and various 
allergic conditions are mediated by immune system. 
Immunological diseases are growing at epidemic 
proportions that require aggressive and innovative 
approaches to develop new treatments. Drugs 
commonly use in immune therapy can modulate the 
immune response in three ways: immunosuppression, 
tolerance, and immunostimulation. The essence of 
immunomodulation is that a pharmacological agent 
acting under various dose and time regimens displays 
an immunomodulating effect (Flemming, 1985; 
Kowalozyk-Bronisz and Paegelow, 1986). The 
immunomodulating action is reversible and requires 
maintaining the dose of a preparation. Natural 
adjuvant, synthetic agents, antibody reagents are used 
as immunosuppressive and immunostimulating agents. 
There are major limitation to the general use of these 
agents such as increased risk of infection and 
generalized effect throughout the immune system 
(Diasio and LoBuglio, 1996). The search for new 
bioactive molecules in plants is of great interest 
considering the diversity of chemical entities produced 
by them (Gottlieb et al., 1996) and the need of new 
medicines for more effective treatment of pathologies 
with lower toxic effects (Oliveira Costa et al., 2008). 
Some studies related to immunomodulatory activity 
were done with an AE of L. divaricata.  Aqueous 
extracts, decoction and infusion from L. divaricata 
were investigated for immunomodulating activity on 
mice peritoneal macrophages (MPhi). The results 
showed that L. divaricata stimulates MPhi activation 
at 0.2 mg/ml whereas it shows a clear pro-apoptotic 
activity at higher concentrations (1 and 4 mg/ml). The 
dual effects found are relevant, considering the folk 
use of this plant to activate the immune system 
(Davicino et al., 2006). Moreover, the author shows 
that the apoptosis triggered by L. divaricata is a 
consequence of cell activation and that the effects are 
independent of NDGA. They concluded that this 
"activation and death" could be the mechanism of L. 
divaricata to exert the anti-tuberculosis effect known 
in folk medicine (Davicino et al., 2007b). With the 
aim to identify the active compounds of the extract, 
the same authors made a fractionation of it. Sub-
fractions without and with low concentrations of 
NDGA were obtained and analyzed on mouse 
macrophages. They observed that, a free NDGA sub-
fraction (F1) at 100 g/ml is capable to activate 
macrophages and decreases NO level, all together 
suggested an anti-inflammatory action. These results 
indicate that NDGA was not the compound 
responsible of the immunomodulatory action exerts by 
the AE of L. divaricata (Martino et al., 2010). On the 
other hand, these authors studied in healthy mice the 
immunomodulatory potential of AE of L. divaricata 
―in vivo‖. They found that the decoction and infusion 
are able to prime Mphi ―in vivo‖ and to induce full 
activation ―in vitro‖ at 0.5 mg/kg. These finding 
contributed to characterize the biological activity of L. 
divaricata and to understand the ability of its extracts 
to enhance immune responses (Davicino et al., 2007c).  
Fractions obtained from L. divaricata were 
assessed ―in vivo― as well (Martino et al., 2011). The 
authors showed that F1 induces a state of pre- 
activation on MPhi ―in vivo‖, which is enhanced by 
the presence of Candida albicans. They postulate that 
F1 could be a good candidate to treat disseminated 
candidiasis by enhancing the innate immune system. 
Besides, Davicino et al. (2008) studied the 
mechanisms by which an AE of L. divaricata releases 
oxygen reactive species ―in vivo‖. They showed that 
the extract at 0.5 mg/kg increases the expression of 
dectin-1 leading to increased superoxide production.  
On the other hand, Mattar et al. (2009) 
characterized the immunogenicity of proteins from a 
partially purified crude aqueous extract (JPCE) of L. 
divaricata and evaluated the cross reaction between 
JPCE and bacterial proteins of Escherichia coli, 
Pseudomonas aeruginosa, Proteus vulgaris, and 
Klebsiella pneumoniae using a mouse anti-JPCE 
serum. Bacterial proteins showed a strong reaction 
with the anti-JPCE serum, suggesting by this way that, 
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proteins from L. divaricata could be used as immune 
stimulants. 
 
Antioxidant effects. 
Taking into account that free radicals are involved in 
several diseases, including cancer, central nervous 
system alterations and inflammatory pathologies, the 
antioxidant activity of an AE of L. divaricata was 
studied.   
Anesini et al. (2004) demonstrated that an AE 
of L. divaricata induces peroxidase secretion by 1 
adrenoreceptors stimulation in submandibulary glands 
of female rats in a dose-dependent manner, reaching a 
maximum activity at 300 g/ml. This effect was not 
related to NDGA as it decreases the peroxidase 
secretion. As well as, both the AE and NDGA 
increases total peroxidase activity, the maximum 
effect of the AE is 6.4 times higher than NDGA.  
Taking together these results, NDGA could be one of 
the active compounds related to the increase of total 
peroxidase activity, but other compounds in the AE 
could be enhanced by NDGA. On the other hand, 
Turner et al. (2011) determined and compared the 
antioxidant activity of AE of L. divaricata and NDGA 
at different concentrations (0.01-10000 g/ml). The 
extract presents peroxidase (Px), catalase (CAT) and 
superoxide dismutase (SOD) like activities.  
Meanwhile, CAT activity is related to the presence of 
NDGA, SOD activity is not.  Also, the extract presents 
inhibitory action of lipid peroxidation as well as free 
radical scavenger effect. Both activities are not related 
to the presence of NDGA. The fact that the extract 
presented stimulatory effect on peroxidase secretion as 
well as peroxidase like activity is very important as 
peroxidase is an oral enzyme implicated in the defense 
of oral cavity, moreover protects against reactive 
oxygen species (ROS). ROS in oral cavity are related 
to the inflammatory events as tissue destruction during 
periodontitis. Also, ROS in the inhaled cigarette 
smoke have been suggested to induce dysplasic lesions 
of the mucosa which then are transformed into ―in 
situ‖ carcinoma lesions eventually resulting in full-
blown infiltrating and metastasizing cancer. In accord 
to said above Turner et al. (2008) postulated the use of 
AE of L. divaricata  as extract or as pharmaceutical 
preparations (mouth rinse, dental cream, gels and 
powders) as oral antioxidant, as well as a agent 
destined to prevent illnesses, among others, cancer and 
peritonitis in human. 
 
 
Other studies 
The effect of an AE of L. divaricata was assayed on 
hair loss. Hair loss is a distressing condition for an 
increasing number of men and women and it is of 
great importance; therefore, to develop new therapies 
for the treatment of this diseases (Rho et al., 2005).  
Davicino et al. (2009b) assayed the effects of L. 
divaricata on hair growth and proposed the topical use 
of association between decaffeinated coffee and L. 
divaricata AE in at least 1000 mg/ml as a possible 
therapeutic agent destined to induce hair growth in 
human and in animals. 
 
Toxicity studies  
About toxicity studies performed with the AE of L. 
divaricata there are only two evidences. In one study 
NDGA, isolated from L. divaricata resin, as well as 
the resin were administered to mice, suggesting that 
NDGA was the main constituent related to the toxic 
effects observed with the resin (Ríos et al., 2008). In 
another study, Davicino et al. (unpublished results) fed 
mice with a dose of 33.4 mg/kg of an AE obtained 
from L. divaricata and demonstrated that mice 
increased weight, consumed more food and preferred 
food with extract. The extract did not modify the 
weight and histology of several organs and did not 
present stimulant or depressant activity. Besides, the 
extract did not present hepatotoxicity and 
nephrotoxicity and did not modify the levels of 
cholesterol and triglycerides, in fact no toxicity signals 
were observed. In this study also, the acute toxicity of 
NDGA and the AE were examined. The authors 
determined that the lethal dose 50 (LD50) of NDGA 
was 60 mg/kg meanwhile, the AE exerted a value of 
40.000 mg/kg (Davicino et al., unpublished results). 
By other way, the NDGA amount determined by 
HPLC in the AE was 0.3- 0.7 w/w. In 33.4 mg/kg of 
extract the animals are ingesting between 0.1-0.2 
mg/kg of NDGA. So, the low toxicity observed could 
be related to the fact that, the dose administered was 
very low in comparison with LD50. 
 
CONCLUSIONS  
Numerous natural products from traditional medicinal 
plants have been introduced in the development of 
new drugs. The objective of this review has been to 
show the advances in the exploration of aqueous 
extracts of L. divaricata as potential therapeutic agent. 
The emphasis is put in the fact that the extract does not 
possess pharmacologically active amounts of NDGA. 
In Table 1 are summarized the pharmacological 
actions of the different extracts of Larrea divaricata. 
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With the current information, it is evident that the AE 
from L. divaricata has pharmacological activities 
including anti-microbial, anti-inflammatory, anti-
cancer effects. The broad applications of AE of this 
plant make it a potential medicine for the treatment of 
several diseases. However, more studies are needed to 
determine the human safety and efficacy of the extract 
to use it in medicine. For these reasons, extensive 
pharmacological studies, referring to 
pharmacodynamic and pharmacokinetic should be 
performed in humans. Also, a phytochemical study 
will be a focus for future studies.  
 
 
 
 
Table 1. Pharmacological effects of aqueous extract obtained from Larrea divaricata Cav. 
Aqueous extract of L. divaricata  
1. Anti-tumor effects:  
                                      -In vitro 
                                          - BW5147 cells 
                                      -In vivo 
                                           -Spontaneous mammary carcinoma in rats. 
                                           -Mammary carcinoma induced with NMU in rats. 
                      
2. Anti-microbial effects: 
                                           -Staphylococcus aureus 
                                           -Helicobacter pylori 
                                           -Saccharomyces cereviceae 
3. Anti-inflammatory activity: 
                                        -Decreases inflammation in mice: 
-Decreases levels of TNF-α. 
-Decreases levels of IL-6. 
-Decreases eosinophil.  
-Increases IL-10. 
4. Immunomodulatory effects: 
                                             -Stimulates macrophages activation in vitro in mice. 
                                             -Shows pro-apoptotic activity at higher concentrations. 
                                             -A sub-fraction from aqueous extract without NDGA   activates mice macrophages and 
decreases NO level. 
                                             -Primes macrophages in vivo in mice.  
                                             -Increases the expression of dectin-1 and increases superoxide production. 
    -Proteins from aqueous extract presents cross reaction with bacterial proteins.  
5. Antioxidant effects:   
                                         -Induces peroxidase secretion by 1 adrenoreceptors stimulation in submandibulary 
glands in rats.  
                                             -Presents peroxidase, catalase and superoxide dismutase like activities. 
                                                -It could be used as oral antioxidant as well as agent destined to prevent cancer and 
peritonitis in human. 
6. Toxic effect: 
                                             -No toxicity signals were observed in mice.  
7. Effect on hair growth: 
                                             -Induces hair growth in mice. 
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